You are entering HCP content only

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

Yes, I am a HCP No, I am not a HCP
placeUnited Kingdom
Contact & Support
Medtronic / Clinical Solutions / Ending Blind D&C

Don't be blind to the evidence

Hysteroscopy and endoscopic biopsies remain as the decisive diagnostic test for intracavitary lesions.1

Request Demo

If you can’t see, you can’t operate

How effective is Hysteroscopy compared with Blind D&C?

Listen to the views of Gynecologic Surgery Specialist Dr. Ido Sirota.

With Blind D&C, you evaluate less than 50% of the uterine cavity in approx. 60% of cases.2

With Hysteroscopy, a correct diagnosis can be made.3

After a Blind D&C, whole or part of the lesion remained in 87% of the cases.4

Whereas, the TruClear™ system provides direct visualization of the uterine cavity with efficient tissue removal in 98% of patients.5

View Info Sheet

Is Blind D&C the most definitive method of diagnosis and treatment for endometrial pathologies?

A recent clinical study, reported a 42% failure to diagnose endometrial polyps.6

With Hysteroscopy, in the same study, reported an 83.9% overall accuracy in the diagnosis of endometrial polyps.6

Is Blind D&C the best method to remove retained products of conception?

Do you know Blind D&C removes only 40% of placental remnants?7

With Hysteroscopy, the Truclear™ System has demonstrated complete RPOC removal in over 94% of patients.8

View Brochure

What are the limitations of blind D&C?

D&C alone will miss benign intrauterine focal pathology such as polyps and submucous fibroids.1

An important drawback of this procedure is being performed blindly.1

Are there risks with blind D&C?

Uterine perforation and small bowl incarceration identified 11 months after Blind D&C.9

D&C procedures have been identified as one of two most important risk factors for Intrauterine Adhesion (IUA).10

Read Clinical Paper

Your diagnosis is 100% because you can see

How effective is Hysteroscopy compared with Blind D&C?

Watch the findings from the Gynecology Expert Prof. Attilio Di Spiezio Sardo.

More videos:

Visual Dilation & Curettage (D&C) with Prof. Attilio Di Spiezio Sardo, Policlinico Universitario Federico II Naples, Italy

Touch Surgery™ - Operative hysteroscopy for RPOC in operating room with TruClear™

Retained Product of Conception (RPOC) with Prof. Attilio Di Spiezio Sardo, Policlinico Universitario Federico II Naples, Italy

Visual Dilation & Curettage (D&C) with TruClear™ Elite Mini with Ursula Catena, M.D. Ph.D CLASS Hysteroscopy Center Fondazione Policlinico Universitario A. Gemeli IRCCS Rome, Italy

Polypectomy with TruClear™ Elite Mini with Ursula Catena, M.D. Ph.D CLASS Hysteroscopy Center Fondazione Policlinico Universitario A. Gemeli IRCCS Rome, Italy

Retained Product of Conception (RPOC) with TruClear™ Elite Mini with Ursula Catena, M.D. Ph.D CLASS Hysteroscopy Center Fondazione Policlinico Universitario A. Gemeli IRCCS Rome, Italy

Don’t be blind to the science

A clear alternative to Blind D&C
"Blind endometrial sampling has gained widespread acceptance with little appropriate validation." 11

The TruClear™ system provides direct visualization of the uterine cavity with efficient tissue removal in 98% of patients.5

View Product Page

Click here to request a demo

Request Demo

References:

1. Karsidag. A, Transvaginal sonography, sonohysterography, and hysteroscopy for investigation of focal intrauterine lesions in women with recurrent postmenopausal bleeding after dilatation & curettage. Arch Gynecol Obstet (2010) 281:637–643 DOI 10.1007/s00404-009-1150-9.

2. Jiang Du, Yaling Li, Shulan Ly, Quing Wang, Chao Sun, Xin Dong, Ming He, Qurat Ulain, Yongxing Yuan, Xiaoqian Tuo, Nasra Batchu, Qing Song – Endometrial sampling devices for early diagnosis of endometrial lesions.

3. Karsidag. A, Transvaginal sonography, sonohysterography, and hysteroscopy for investigation of focal intrauterine lesions in women with recurrent postmenopausal bleeding after dilatation & curettage. Arch Gynecol Obstet (2010) 281:637–643 DOI 10.1007/s00404-009-1150-9.

4. Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2001;80(12):1131–1136.

5. Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps. Obstet Gynecol. 2014;123(4):745–751.

6. Ergenoglu AM, Hortu I, Taylan E, Yeniel AO, Akdemir A, Sahin C, Karadadas N. Can we rely on blind endometrial curettage for complete removal of focal intrauterine lesion? A prospective clinical study. J Gynecol Obstet Hum Reprod. 2020 Apr;49(4):101696. doi: 10.1016/j.jogoh.2020.101696. Epub 2020 Feb 1.

7. Dreisler E, Kjer JJ. Asherman’s syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019;11:191-198. Published 2019 Mar 20. doi:10.2147/IJWH.S165474.

8. Emanuel MH, Womstaker K. A new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol. 2005; 12(1):62–66.

9. Cicco A.De, et al. Uterine perforation and small bowel incarceration 11 months after dilatation and curettage: sonographic and surgical fi ndings Ultrasound Obstet Gynecol 2017; 49: 275–278.

10. Xueying Li, Ling Wu, Yanfei Zhou, Xing Fan, Jufang Huang, Juhua Wu, Renxiu Yu, Jianying Lou, Mengjie Yang, Zhihong Yao, Min Xue, New Crosslinked Hyaluronan Gel for the Prevention of Intrauterine Adhesions After Dilation and Curettage in Patients With Delayed Miscarriage: A Prospective, Multicenter, Randomized, Controlled Trial, The Journal of Minimally Invasive Gynecology (2018), https://doi.org/10.1016/j.jmig.2018.03.032.

11. Goldstein, S.R. Modern Evlauation of the Endomentrium. Obstetrics & Gynecology vol. 116, no. 1, July 2010.